​

Moleculin Biotech Ownership | Who Owns Moleculin Biotech?

OverviewForecastRevenueFinancialsChartTranscripts

Moleculin Biotech Ownership Summary

Moleculin Biotech is owned by 15.82% institutional investors, 0.71% insiders, and 83.47% retail investors. Vanguard US Total Market Shares ETF is the top mutual fund, with 0.97% of its assets in Moleculin Biotech shares.

MBRX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockMoleculin Biotech15.82%0.71%83.47%
SectorHealthcare Stocks 279.15%10.63%-189.78%
IndustryBiotech Stocks 63.94%10.67%25.38%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20252110.53%1,478,032218.10%158.69%1122.22%2-60.00%
Dec 31, 20241911.76%464,6500.89%138.78%912.50%566.67%
Sep 30, 20241713.33%460,56346.81%128.15%8-20.00%350.00%
Jun 30, 202415-16.67%313,72221.38%1211.23%10233.33%2-86.67%
Mar 31, 202418-21.74%258,464-95.01%100.02%3-70.00%15275.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF40.47K0.97%-13.02K
Vanguard Total Stock Mkt Idx Inv16.86K0.56%-23.61K
Vanguard Institutional Extnd Mkt Idx Tr30.31K0.21%-
Fidelity Extended Market Index18.49K0.08%-
Fidelity Series Total Market Index14.32K0.06%10.06K
SSgA U.S. Extended Market Index Class I11.70K0.03%-
NT Ext Eq Mkt Indx Fd DC Lend T4414.000.01%414.00
NT Ext Eq Mkt Indx Fd DC Lend T3414.000.01%414.00
Schwab Total Stock Market Index366.000.01%-
Fidelity Total Market Index2.06K0.01%-

Recent Insider Transactions

DateNameRoleActivityValue
Jun 23, 2025Foster Jonathan P. Chief Financial OfficerBuy$100.00K
Jun 23, 2025Foster Jonathan P. Chief Financial OfficerSell$300.00K
Jun 23, 2025KLEMP WALTER V CEO and PresidentSell$750.00K
Jun 23, 2025KLEMP WALTER V CEO and PresidentBuy$250.00K
Dec 26, 2023Foster Jonathan P. Chief Financial OfficerBuy$20.00K

Insider Transactions Trends

DateBuySell
2025 Q24-
2024 Q4--
2024 Q3--
2024 Q2--
2023 Q43-

MBRX Ownership FAQ

Who Owns Moleculin Biotech?

Moleculin Biotech shareholders are primarily institutional investors at 15.82%, followed by 0.71% insiders and 83.47% retail investors. The average institutional ownership in Moleculin Biotech's industry, Biotech Stocks , is 63.94%, which Moleculin Biotech falls below.

Does Blackrock own Moleculin Biotech?

BlackRock is not among the top 10 institutional shareholders of Moleculin Biotech.

Who is the top mutual fund holder of Moleculin Biotech shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Moleculin Biotech shares, with 0.97% of its total shares outstanding invested in 40.47K Moleculin Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools